Profile data is unavailable for this security.
About the company
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
- Revenue in CAD (TTM)36.99m
- Net income in CAD-13.61m
- Incorporated2017
- Employees166.00
- LocationMedipharm Labs Corp151 John StreetBARRIE L4N 2L1CanadaCAN
- Phone+1 (705) 719-7425
- Fax+1 (705) 719-7425
- Websitehttps://www.medipharmlabs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Devonian Health Group Inc | 5.03m | -4.28m | 28.97m | 6.00 | -- | 2.17 | -- | 5.76 | -0.0304 | -0.0304 | 0.0352 | 0.0897 | 0.2723 | 16.81 | 3.47 | 838,660.00 | -23.17 | -21.02 | -30.01 | -23.96 | 37.90 | 29.96 | -85.08 | -131.97 | 1.11 | -15.22 | 0.0113 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |
| Cytophage Technologies Ltd | 0.00 | -4.64m | 29.09m | -- | -- | 12.23 | -- | -- | -0.5489 | -0.5489 | 0.00 | 0.0442 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -165.33 | 0.8283 | -- | -- | -- | -25.88 | -- | -- | -- |
| Nurexone Biologic Inc | 0.00 | -4.97m | 32.32m | 8.00 | -- | 91.63 | -- | -- | -0.1127 | -0.1127 | 0.00 | 0.0054 | 0.00 | -- | -- | -- | -146.66 | -213.78 | -294.38 | -596.97 | -- | -- | -- | -- | -- | -- | 0.0105 | -- | -- | -- | 55.45 | -- | -- | -- |
| Avicanna Inc | 22.07m | -7.25m | 32.77m | 38.00 | -- | -- | -- | 1.48 | -0.0808 | -0.0808 | 0.2477 | -0.0055 | 1.12 | 3.07 | 12.26 | 580,708.40 | -36.83 | -67.17 | -282.36 | -167.73 | 47.29 | 46.36 | -32.86 | -368.82 | 0.3163 | -10.44 | 0.1834 | -- | 314.82 | 169.57 | 40.67 | -- | -32.29 | -- |
| Thiogenesis Therapeutics Corp | 0.00 | -5.06m | 33.74m | -- | -- | 5.96 | -- | -- | -0.1289 | -0.1289 | 0.00 | 0.1241 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Medipharm Labs Corp | 36.99m | -13.61m | 34.42m | 166.00 | -- | 0.6889 | -- | 0.9305 | -0.0382 | -0.0382 | 0.1017 | 0.1234 | 0.600 | 3.44 | 3.90 | 222,831.30 | -22.07 | -32.88 | -26.27 | -39.56 | 16.37 | -5.88 | -36.78 | -67.66 | 2.20 | -- | 0.0407 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
| Simply Better Brands Corp | 109.02m | -33.11m | 35.10m | -- | -- | -- | -- | 0.322 | -0.4616 | -0.4616 | 1.54 | -0.0684 | 2.84 | 6.79 | 22.87 | -- | -86.36 | -63.90 | -460.44 | -215.48 | 58.69 | -- | -30.37 | -29.46 | 0.298 | -8.19 | 1.65 | -- | 22.08 | -- | -96.41 | -- | -- | -- |
| Medicus Pharma Ltd | 0.00 | -8.02m | 35.62m | -- | -- | 32.30 | -- | -- | -1.25 | -1.25 | 0.00 | 0.0681 | 0.00 | -- | -- | -- | -539.96 | -652.37 | -- | -- | -- | -- | -- | -- | -- | -7.90 | 0.00 | -- | -- | -- | -300.86 | -- | -- | -- |
| Eastwood Bio-Medical Canada Inc | 736.75k | -531.60k | 37.97m | -- | -- | -- | -- | 51.54 | -0.0077 | -0.0077 | 0.0107 | -0.013 | 1.63 | -- | 38.65 | -- | -117.75 | -52.23 | -- | -140.29 | 60.00 | 52.09 | -72.15 | -52.90 | -- | -227.16 | -- | -- | -33.22 | 3.13 | -264.69 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -17.21m | 38.48m | 5.00 | -- | -- | -- | -- | -1.11 | -1.11 | 0.00 | -0.6896 | 0.00 | -- | -- | -- | -54.70 | -59.37 | -60.36 | -63.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 24.35 | -- | -- | -- |
| Charlotte's Web Holdings Inc | 79.55m | -41.66m | 38.61m | 164.00 | -- | 0.6046 | -- | 0.4853 | -0.2716 | -0.2716 | 0.5182 | 0.4052 | 0.3668 | 1.07 | 27.08 | 485,053.90 | -19.21 | -25.71 | -22.16 | -29.03 | 55.88 | 48.98 | -52.37 | -63.11 | 2.33 | -- | 0.478 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
| Medexus Pharmaceuticals Inc | 157.99m | 8.03m | 39.71m | 98.00 | 4.45 | 0.9818 | 2.48 | 0.2514 | 0.3637 | 0.3637 | 7.27 | 1.65 | 0.7547 | 2.19 | 5.44 | 1,612,120.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Penserra Capital Management LLCas of 09 May 2024 | 2.93m | 0.73% |
